BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15702857)

  • 1. Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin.
    Toracchio S; Capodicasa S; Soraja DB; Cellini L; Marzio L
    Dig Liver Dis; 2005 Jan; 37(1):33-8. PubMed ID: 15702857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
    Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
    Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.
    Moayyedi P; Ragunathan PL; Mapstone N; Axon AT; Tompkins DS
    J Gastroenterol; 1998; 33 Suppl 10():62-5. PubMed ID: 9840021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy.
    Kao AW; Cheng HC; Sheu BS; Lin CY; Sheu MJ; Yang HB; Wu JJ
    J Gen Intern Med; 2005 Feb; 20(2):139-42. PubMed ID: 15836546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan.
    Hoshiya S; Watanabe K; Tokunaga K; Tanaka A; Ninomiya H; Shingaki M; Itoh T; Saito S; Ishida H; Takahashi S
    J Gastroenterol; 2000; 35(1):10-4. PubMed ID: 10632534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
    Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
    J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.
    Fiorini G; Vakil N; Zullo A; Saracino IM; Castelli V; Ricci C; Zaccaro C; Gatta L; Vaira D
    Clin Gastroenterol Hepatol; 2013 May; 11(5):507-10. PubMed ID: 23267869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome.
    Adamek RJ; Suerbaum S; Pfaffenbach B; Opferkuch W
    Am J Gastroenterol; 1998 Mar; 93(3):386-9. PubMed ID: 9517645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
    Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Failure of Helicobacter pylori eradication--suggestions for further therapy].
    Prónai L; Tulassay Z
    Orv Hetil; 2003 Jun; 144(26):1299-302. PubMed ID: 12894674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
    Bhatia V; Ahuja V; Das B; Bal C; Sharma MP
    J Gastroenterol Hepatol; 2004 Jun; 19(6):619-25. PubMed ID: 15151614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
    Oderda G; Marinello D; Lerro P; Kuvidi M; de'Angelis GL; Ferzetti A; Cucchiara S; Franco MT; Romano C; Strisciuglio P; Pensabene L
    Helicobacter; 2004 Aug; 9(4):293-301. PubMed ID: 15270743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication.
    Danese S; Armuzzi A; Romano A; Cremonini F; Candelli M; Franceschi F; Ojetti V; Venuti A; Pola P; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2001; 48(38):465-7. PubMed ID: 11379334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
    Miehlke S; Hansky K; Schneider-Brachert W; Kirsch C; Morgner A; Madisch A; Kuhlisch E; Bästlein E; Jacobs E; Bayerdörffer E; Lehn N; Stolte M
    Aliment Pharmacol Ther; 2006 Jul; 24(2):395-403. PubMed ID: 16842467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.